Supply of Proprietary IHC Reagent Kits

The contract specifies the manufacture and supply of proprietary immunohistochemistry reagent kits designed to be fully compatible with Roche diagnostic platforms. These kits include clinically validated antibodies and detection systems intended for use in clinical laboratories to support accurate tissue-based diagnostics. The products must meet stringent quality and performance standards to ensure consistency with Roche’s existing instrumentation and workflows, enabling seamless integration into existing clinical pathology settings. This is a subcontract under the Department of Veterans Affairs’ 242-NETWORK Contract Office 02, with a NAICS code of 325412 indicating pharmaceutical and medicine manufacturing. The solicitation was posted on July 22, 2026, and responses are due by July 30, 2026. Performance is not restricted to a specific geographic location, allowing for flexible manufacturing and distribution arrangements. The supplier must deliver reagent kits that comply with regulatory requirements for diagnostic medical devices and maintain compatibility across Roche platforms to support reliable, reproducible results in routine clinical use.